Paul W. Harms, Ph.D. - Publications

Affiliations: 
2006 University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Cell Biology

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Huang C, Runge M, Hrycaj SM, Harms PW, Fullen DR, Chan MP. Proliferating inverted follicular keratosis of genital skin: Case series of a challenging variant. Journal of Cutaneous Pathology. PMID 38736174 DOI: 10.1111/cup.14644  0.317
2023 Menge TD, Durgin JS, Hrycaj SM, Brent AA, Patel RM, Harms PW, Fullen DR, Chan MP, Bresler SC. Utility of GLI1 RNA chromogenic in situ hybridization in distinguishing basal cell carcinoma from histopathologic mimics. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 100265. PMID 37391171 DOI: 10.1016/j.modpat.2023.100265  0.343
2022 Verhaegen ME, Harms PW, Van Goor JJ, Arche J, Patrick MT, Wilbert D, Zabawa H, Grachtchouk M, Liu CJ, Hu K, Kelly MC, Chen P, Saunders TL, Weidinger S, Syu LJ, et al. Direct cellular reprogramming enables development of viral T antigen-driven Merkel cell carcinoma in mice. The Journal of Clinical Investigation. PMID 35143422 DOI: 10.1172/JCI152069  0.322
2022 Kline N, Menge TD, Hrycaj SM, Andea AA, Patel RM, Harms PW, Chan MP, Bresler SC. PRAME Expression in Challenging Dermal Melanocytic Neoplasms and Soft Tissue Tumors With Melanocytic Differentiation. The American Journal of Dermatopathology. PMID 34991102 DOI: 10.1097/DAD.0000000000002128  0.305
2021 Plotzke JM, Adams DJ, Harms PW. Molecular pathology of skin adnexal tumors. Histopathology. PMID 34197659 DOI: 10.1111/his.14441  0.302
2020 Jarocki C, Kozlow J, Harms PW, Schmidt BM. Eccrine Porocarcinoma: Avoiding Diagnostic Delay. Foot & Ankle Specialist. 13: 415-419. PMID 32924585 DOI: 10.1177/1938640020946190  0.301
2020 Arora R, Choi JE, Harms PW, Chandrani P. Merkel Cell Polyomavirus in Merkel Cell Carcinoma: Integration Sites and Involvement of the KMT2D Tumor Suppressor Gene. Viruses. 12. PMID 32878339 DOI: 10.3390/V12090966  0.356
2020 Gudjonsson JE, Tsoi LC, Ma F, Billi AC, van Straalen KR, Vossen AR, Zee HH, Harms PW, Wasikowski R, Yee CM, Rizvi SM, Xing X, Xing E, Plazyo O, Zeng C, et al. Contribution of plasma cells and B-cells to hidradenitis suppurativa pathogenesis. Jci Insight. PMID 32853177 DOI: 10.1172/Jci.Insight.139930  0.303
2020 Talsma CE, Wang M, Andea AA, Fullen DR, Harms PW, Chan MP. Expression of p16 in Merkel Cell Carcinoma. Journal of Cutaneous Pathology. PMID 32592172 DOI: 10.1111/Cup.13790  0.352
2020 Miller TI, Zoumberos NA, Johnson B, Rhodes DR, Tomlins SA, Chan MP, Andea AA, Lucas DR, McHugh JB, Smith N, Harms KL, Brewer C, Saleh J, Patel RM, Harms PW. A Genomic Survey of Sarcomas on Sun-Exposed Skin Reveals Distinctive Candidate Drivers and Potentially Targetable Mutations. Human Pathology. PMID 32540221 DOI: 10.1016/J.Humpath.2020.06.003  0.365
2020 Lazo de la Vega L, Bick N, Hu K, Rahrig SE, Silva CD, Matayoshi S, Picciarelli P, Wang X, Sugar A, Soong HK, Mian SI, Robinson DR, Chinnaiyan AM, Demirci H, Daniels AB, ... ... Harms PW, et al. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32461624 DOI: 10.1038/S41379-020-0571-7  0.399
2020 Alomari AK, Miedema JR, Carter MD, Harms PW, Lowe L, Durham AB, Fullen DR, Patel RM, Hristov AC, Chan MP, Wang M, Andea AA. DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approach. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32066860 DOI: 10.1038/S41379-020-0499-Y  0.321
2020 Verhaegen ME, Goor JV, Arche J, Harms P, Wilbert D, Zabawa H, Patrick M, Tsoi LC, Chinnaiyan A, Dlugosz AA. 118 In vivo cellular reprogramming facilitates viral T antigen-driven Merkel cell carcinoma development in adult mice Journal of Investigative Dermatology. 140. DOI: 10.1016/J.Jid.2020.03.121  0.311
2019 Maloney N, Smith SM, Peters SB, Batistatou A, Evangelou Z, Harms PW, Chan MP, Antonescu CR, Linos K. Expanding the differential of superficial tumors with round cell morphology: report of three cases of CIC-rearranged sarcoma, a potentially under-recognized entity. Journal of Cutaneous Pathology. PMID 31886887 DOI: 10.1111/Cup.13639  0.375
2019 Chan MP, Plouffe KR, Liu CJ, Palanisamy N, Carskadon S, Zhao L, Nazarian RM, Durham AB, Johnson TM, Andea AA, Patel RM, Lowe L, Fullen DR, Brown NA, Tomlins SA, ... ... Harms PW, et al. Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31857679 DOI: 10.1038/S41379-019-0424-4  0.419
2019 Tetzlaff MT, Harms PW. Danger is only skin deep: aggressive epidermal carcinomas. An overview of the diagnosis, demographics, molecular-genetics, staging, prognostic biomarkers, and therapeutic advances in Merkel cell carcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31676786 DOI: 10.1038/S41379-019-0394-6  0.37
2019 Shao S, Tsoi LC, Sarkar MK, Xing X, Xue K, Uppala R, Berthier CC, Zeng C, Patrick M, Billi AC, Fullmer J, Beamer MA, Perez-White B, Getsios S, Schuler A, ... ... Harms P, et al. IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. Science Translational Medicine. 11. PMID 31554739 DOI: 10.1126/Scitranslmed.Aav7561  0.318
2019 Friedman BJ, Hernandez S, Fidai C, Jiang A, Shwayder TA, Carskadon S, Andea AA, Harms PW, Chitale D, Palanisamy N. A pediatric case of pigmented epithelioid melanocytoma with chromosomal copy number alterations in 15q and 17q and a novel NTRK3-SCAPER gene fusion. Journal of Cutaneous Pathology. PMID 31437301 DOI: 10.1111/Cup.13566  0.367
2019 Schuler A, Smith M, Zahn J, Wang M, Noh I, Chan MP, Andea AA, Harms PW. A Case of Adjacent, Clonally Distinct Borderline Melanocytic Tumors on the Arm. The American Journal of Dermatopathology. PMID 31268925 DOI: 10.1097/Dad.0000000000001472  0.394
2019 Rashid M, van der Horst M, Mentzel T, Butera F, Ferreira I, Pance A, Rütten A, Luzar B, Marusic Z, de Saint Aubain N, Ko JS, Billings SD, Chen S, Abi Daoud M, Hewinson J, ... ... Harms PW, et al. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma. Nature Communications. 10: 2213. PMID 31101826 DOI: 10.1038/S41467-019-09979-0  0.356
2019 Young KZ, Raisanen TD, Else T, Harms PW, Cha KB. A few pink papules in an adult woman: Incidental finding leads to diagnosis of hereditary leiomyomatosis and renal cell cancer. Jaad Case Reports. 5: 419-421. PMID 31049386 DOI: 10.1016/J.Jdcr.2019.02.027  0.369
2019 Zahn J, Chan MP, Wang G, Patel RM, Andea AA, Bresler SC, Harms PW. Altered RB, p16, or p53 expression is specific for porocarcinoma relative to poroma. Journal of Cutaneous Pathology. PMID 31012122 DOI: 10.1111/Cup.13480  0.379
2019 Billi AC, Gharaee-Kermani M, Fullmer J, Tsoi LC, Hill BD, Gruszka D, Ludwig J, Xing X, Estadt S, Wolf SJ, Rizvi SM, Berthier CC, Hodgin JB, Beamer MA, Sarkar MK, ... ... Harms PW, et al. The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity. Jci Insight. 4. PMID 30996136 DOI: 10.1172/Jci.Insight.127291  0.313
2019 Wang GY, Thomas DG, Davis JL, Ng T, Patel RM, Harms PW, Betz BL, Schuetze SM, McHugh JB, Horvai AE, Cho SJ, Lucas DR. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor. The American Journal of Surgical Pathology. PMID 30994538 DOI: 10.1097/Pas.0000000000001260  0.355
2019 Choi JE, Verhaegen ME, Yazdani S, Malik R, Harms PW, Mangelberger D, Tien J, Cao X, Wang Y, Cieślik M, Gurkan J, Yazdani M, Jing X, Juckette K, Su F, et al. Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma. Neoplasia (New York, N.Y.). 21: 322-330. PMID 30797188 DOI: 10.1016/J.Neo.2019.01.003  0.353
2019 Wong K, van der Weyden L, Schott CR, Foote A, Constantino-Casas F, Smith S, Dobson JM, Murchison EP, Wu H, Yeh I, Fullen DR, Joseph N, Bastian BC, Patel RM, Martincorena I, ... ... Harms PW, et al. Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma. Nature Communications. 10: 353. PMID 30664638 DOI: 10.1038/S41467-018-08081-1  0.346
2019 Bitar C, Fullen DR, Harms PW. An update on diagnostic features of Merkel cell carcinoma Diagnostic Histopathology. 25: 110-119. DOI: 10.1016/J.Mpdhp.2018.12.007  0.423
2019 Hill NT, Collado L, Harms PW, Brownell I. 519 Paranuclear cytokeratin aggregates help Merkel cell carcinoma evade extrinsic apoptosis Journal of Investigative Dermatology. 139. DOI: 10.1016/J.Jid.2019.07.569  0.325
2019 Verhaegen ME, Mangelberger D, Wilbert D, VanGoor J, Harms P, Dlugosz AA. 132 Atoh1 is required for maintenance of Merkel cell carcinoma lineage identity Journal of Investigative Dermatology. 139. DOI: 10.1016/J.Jid.2019.03.208  0.355
2018 Zoumberos N, McMullen E, Wang L, Wang X, Harms KL, Tejasvi T, Chan MP, Fullen DR, Hristov A, Harms PW. Merkel Cell Carcinoma Arising in Association with Cutaneous T-cell Lymphoma: A Potential Diagnostic Pitfall. Journal of Cutaneous Pathology. PMID 30561044 DOI: 10.1111/Cup.13404  0.387
2018 Falto Aizpurua LA, Wang M, Ruiz HA, Sánchez JL, Chan MP, Andea AA, Harms PW. A case of combined Merkel cell carcinoma and squamous cell carcinoma: Molecular insights and diagnostic pitfalls. Jaad Case Reports. 4: 996-999. PMID 30417062 DOI: 10.1016/J.Jdcr.2018.08.004  0.451
2018 Harms PW, Harms KL, Moore PS, DeCaprio JA, Nghiem P, Wong MKK, Brownell I. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. Nature Reviews. Clinical Oncology. PMID 30287935 DOI: 10.1038/S41571-018-0103-2  0.349
2018 Stanoszek LM, Chan MP, Palanisamy N, Carskadon S, Siddiqui J, Patel RM, Harms KL, Lowe L, Fullen DR, Harms PW. Neurofilament is Superior to Cytokeratin 20 in Supporting Cutaneous Origin for Neuroendocrine Carcinoma. Histopathology. PMID 30239030 DOI: 10.1111/His.13758  0.383
2018 Saleh J, Wang ML, Harms PW, Patel RM, Fullen DR. Malignant Melanoma with Osteosarcomatous Differentiation in a Lymph Node Metastasis. Journal of Cutaneous Pathology. PMID 29781204 DOI: 10.1111/Cup.13283  0.336
2018 Eberl M, Mangelberger D, Swanson JB, Verhaegen ME, Harms PW, Frohm ML, Dlugosz AA, Wong SY. Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma. Cancer Cell. PMID 29395868 DOI: 10.1016/J.Ccell.2017.12.015  0.379
2018 Verhaegen M, Mangelberger D, Harms P, Wilbert D, Zabawa H, Goor JV, Kelly M, Chen P, Dlugosz A. 195 Postnatal initiation of MCC-like tumor development in mice co-expressing Merkel cell polyomavirus T antigens and ATOH1 Journal of Investigative Dermatology. 138. DOI: 10.1016/J.Jid.2018.03.200  0.324
2017 Stanoszek LM, Wang GY, Harms PW. Histologic Mimics of Basal Cell Carcinoma. Archives of Pathology & Laboratory Medicine. 141: 1490-1502. PMID 29072946 DOI: 10.5858/Arpa.2017-0222-Ra  0.429
2017 Schuler A, Smith E, Chen S, Chan MP, Harms PW. Psammomatous Squamous Cell Carcinoma of the Skin. The American Journal of Dermatopathology. PMID 28953015 DOI: 10.1097/Dad.0000000000001001  0.405
2017 Skala SL, Arps DP, Zhao L, Cha KB, Wang M, Harms PW, Andea AA, Fullen DR, Chan MP. Comprehensive Histopathologic Comparison of Epidermotropic/Dermal Metastatic Melanoma and Primary Nodular Melanoma. Histopathology. PMID 28881040 DOI: 10.1111/His.13384  0.351
2017 Smith SC, Gooding WE, Elkins M, Patel RM, Harms PW, McDaniel AS, Palanisamy N, Uram-Tuculescu C, Balzer BB, Lucas DR, Seethala RR, McHugh JB. Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic Study. The American Journal of Surgical Pathology. PMID 28877055 DOI: 10.1097/Pas.0000000000000940  0.346
2017 Udager AM, Frisch NK, Hong LJ, Stasenko M, Johnston CM, Liu JR, Chan MP, Harms PW, Fullen DR, Orsini A, Thomas DG, Lowe L, Patel RM. Gynecologic melanomas: A clinicopathologic and molecular analysis. Gynecologic Oncology. PMID 28844540 DOI: 10.1016/J.Ygyno.2017.08.023  0.348
2017 Harms PW. Update on Merkel Cell Carcinoma. Clinics in Laboratory Medicine. 37: 485-501. PMID 28802497 DOI: 10.1016/J.Cll.2017.05.004  0.425
2017 Lazo de la Vega L, McHugh JB, Cani AK, Kunder K, Walocko FM, Liu CJ, Hovelson DH, Robinson DR, Chinnaiyan AM, Tomlins SA, Harms PW. Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable FGFR3 Amplifications. Molecular Cancer Research : McR. PMID 28775129 DOI: 10.1158/1541-7786.Mcr-17-0135  0.339
2017 Harms KL, Chubb H, Zhao L, Fullen DR, Bichakjian CK, Johnson TM, Carskadon S, Palanisamy N, Harms PW. Increased Expression of EZH2 in Merkel Cell Carcinoma Is Associated with Disease Progression and Poorer Prognosis. Human Pathology. PMID 28739498 DOI: 10.1016/J.Humpath.2017.07.009  0.409
2017 Wang L, Harms PW, Palanisamy N, Carskadon S, Cao X, Siddiqui J, Patel RM, Zelenka-Wang S, Durham AB, Fullen DR, Harms K, Su F, Shukla S, Mehra R, Chinnaiyan AM. Age and gender associations of virus positivity in Merkel cell carcinoma characterized using a novel RNA in situ hybridization assay. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28606924 DOI: 10.1158/1078-0432.Ccr-17-0299  0.341
2017 Verhaegen ME, Mangelberger D, Harms PW, Eberl M, Wilbert DM, Meireles J, Bichakjian CK, Saunders TL, Wong SY, Dlugosz AA. Merkel cell polyomavirus small T antigen initiates Merkel cell carcinoma-like tumor development in mice. Cancer Research. PMID 28512245 DOI: 10.1158/0008-5472.Can-17-0035  0.403
2017 Harms KL, Lazo de la Vega L, Hovelson DH, Rahrig S, Cani AK, Liu CJ, Fullen DR, Wang M, Andea AA, Bichakjian CK, Johnson TM, Tomlins SA, Harms PW. Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases. Jama Dermatology. PMID 28403382 DOI: 10.1001/Jamadermatol.2017.0507  0.428
2017 Walocko FM, Scheier BY, Harms PW, Fecher LA, Lao CD. Erratum to: Metastatic Merkel cell carcinoma response to nivolumab. Journal For Immunotherapy of Cancer. 5: 27. PMID 28286652 DOI: 10.1186/S40425-017-0221-X  0.329
2017 Potu H, Peterson LF, Kandarpa M, Pal A, Sun H, Durham A, Harms PW, Hollenhorst PC, Eskiocak U, Talpaz M, Donato NJ. Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma. Nature Communications. 8: 14449. PMID 28198367 DOI: 10.1038/Ncomms14449  0.303
2017 Verhaegen ME, Mangelberger D, Harms PW, Eberl M, Wilbert D, Meireles J, Zabawa H, Saunders T, Dlugosz AA. 143 Merkel cell carcinoma-like tumor development in mice is dependent on the FBXW7 binding domain of Merkel cell polyomavirus small T antigen Journal of Investigative Dermatology. 137. DOI: 10.1016/J.Jid.2017.02.157  0.358
2016 Walocko FM, Scheier BY, Harms PW, Fecher LA, Lao CD. Metastatic Merkel cell carcinoma response to nivolumab. Journal For Immunotherapy of Cancer. 4: 79. PMID 27879975 DOI: 10.1186/S40425-016-0186-1  0.303
2016 Harms PW, Hocker TL, Zhao L, Chan MP, Andea AA, Wang M, Harms KL, Wang ML, Carskadon S, Palanisamy N, Fullen DR. Loss of p16 Expression and Copy Number Changes of CDKN2A in a Spectrum of Spitzoid Melanocytic Lesions. Human Pathology. PMID 27569296 DOI: 10.1016/J.Humpath.2016.07.029  0.337
2016 Bax MJ, Johnson TM, Harms PW, Schwartz JL, Zhao L, Fullen DR, Chan MP. Detection of Occult Invasion in Melanoma In Situ. Jama Dermatology. PMID 27533878 DOI: 10.1001/Jamadermatol.2016.2668  0.326
2016 Strizzi L, Margaryan NV, Gerami P, Haghighat Z, Harms PW, Madonna G, Botti G, Ascierto PA, Hendrix MJ. Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi. Oncology Letters. 12: 1349-1354. PMID 27446436 DOI: 10.3892/Ol.2016.4755  0.333
2016 Rittié L, Tejasvi T, Harms PW, Xing X, Nair RP, Gudjonsson JE, Swindell WR, Elder JT. Sebaceous gland atrophy in psoriasis: An explanation for psoriatic alopecia? The Journal of Investigative Dermatology. PMID 27312025 DOI: 10.1016/J.Jid.2016.05.113  0.306
2016 Minca EC, Al-Rohil RN, Wang M, Harms PW, Ko JS, Collie AM, Kovalyshyn I, Prieto VG, Tetzlaff MT, Billings SD, Andea AA. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27174586 DOI: 10.1038/Modpathol.2016.84  0.335
2016 Harms PW, Hovelson DH, Cani AK, Omata K, Haller MJ, Wang ML, Arps D, Patel RM, Fullen DR, Wang M, Siddiqui J, Andea A, Tomlins SA. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations. Human Pathology. 51: 25-31. PMID 27067779 DOI: 10.1016/J.Humpath.2015.12.015  0.317
2016 East E, Fullen DR, Arps D, Patel RM, Palanisamy N, Carskadon S, Harms PW. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin. The American Journal of Dermatopathology. PMID 27043336 DOI: 10.1097/Dad.0000000000000541  0.402
2016 Chan MP, Andea AA, Harms PW, Durham AB, Patel RM, Wang M, Robichaud P, Fisher GJ, Johnson TM, Fullen DR. Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26743478 DOI: 10.1038/Modpathol.2015.153  0.328
2016 Harms PW, Collie AM, Hovelson DH, Cani AK, Verhaegen ME, Patel RM, Fullen DR, Omata K, Dlugosz AA, Tomlins SA, Billings SD. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26743471 DOI: 10.1038/Modpathol.2015.154  0.426
2016 Miner AG, Patel RM, Wilson D, Procop GW, Minca E, Fullen DR, Harms PW, Billings SD. Reply to Commentary on "Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus". Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 29: 90-1. PMID 26715062 DOI: 10.1038/Modpathol.2015.125  0.359
2016 Mangelberger D, Verhaegen M, Harms P, Durham A, Kozlow J, Cederna P, Bichakjian C, Johnson T, Dlugosz A. 098 Co-expression of epidermal keratins and neuroendocrine markers in Merkel cell carcinoma tumors and cell lines Journal of Investigative Dermatology. 136: S18. DOI: 10.1016/J.Jid.2016.02.124  0.397
2016 Verhaegen ME, Mangelberger D, Harms PW, Wilbert D, Meireles J, Saunders T, Dlugosz AA. 092 Merkel cell polyomavirus small T antigen co-expressed with Atoh1 drives development of intraepidermal MCC Journal of Investigative Dermatology. 136. DOI: 10.1016/J.Jid.2016.02.118  0.427
2015 Harms KL, Lowe L, Fullen DR, Harms PW. Atypical Spitz Tumors: A Diagnostic Challenge. Archives of Pathology & Laboratory Medicine. 139: 1263-70. PMID 26414472 DOI: 10.5858/Arpa.2015-0207-Ra  0.381
2015 Harms PW, Vats P, Verhaegen ME, Robinson DR, Wu YM, Dhanasekaran SM, Palanisamy N, Siddiqui J, Cao X, Su F, Wang R, Xiao H, Kunju LP, Mehra R, Tomlins SA, et al. The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma. Cancer Research. PMID 26238782 DOI: 10.1158/0008-5472.Can-15-0702  0.35
2015 Demicco EG, Harms PW, Patel RM, Smith SC, Ingram D, Torres K, Carskadon SL, Camelo-Piragua S, McHugh JB, Siddiqui J, Palanisamy N, Lucas DR, Lazar AJ, Wang WL. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. American Journal of Clinical Pathology. 143: 672-82. PMID 25873501 DOI: 10.1309/Ajcpn25Njtounpnf  0.345
2015 Harms PW, Fullen DR, Patel RM, Chang D, Shalin SC, Ma L, Wood B, Beer TW, Siddiqui J, Carskadon S, Wang M, Palanisamy N, Fisher GJ, Andea A. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses. Human Pathology. 46: 690-7. PMID 25704628 DOI: 10.1016/J.Humpath.2015.01.006  0.384
2015 Miner AG, Patel RM, Wilson DA, Procop GW, Minca EC, Fullen DR, Harms PW, Billings SD. Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 498-504. PMID 25394777 DOI: 10.1038/Modpathol.2014.148  0.402
2015 Verhaegen ME, Mangelberger D, Harms PW, Vozheiko TD, Weick JW, Wilbert DM, Saunders TL, Ermilov AN, Bichakjian CK, Johnson TM, Imperiale MJ, Dlugosz AA. Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. The Journal of Investigative Dermatology. 135: 1415-24. PMID 25313532 DOI: 10.1038/Jid.2014.446  0.376
2014 Fisher CA, Harms PW, McHugh JB, Edwards PC, Siddiqui J, Palanisamy N, Bichakjian CK, Benavides E, Danciu TE. Small cell carcinoma in the parotid harboring Merkel cell polyomavirus. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 118: 703-12. PMID 25457888 DOI: 10.1016/J.Oooo.2014.09.012  0.382
2014 Pletneva MA, Andea A, Palanisamy N, Betz BL, Carskadon S, Wang M, Patel RM, Fullen DR, Harms PW. Clear cell melanoma: a cutaneous clear cell malignancy. Archives of Pathology & Laboratory Medicine. 138: 1328-36. PMID 25268196 DOI: 10.5858/Arpa.2014-0307-Cc  0.431
2014 Ha Lan TT, Chen SJ, Arps DP, Fullen DR, Patel RM, Siddiqui J, Carskadon S, Palanisamy N, Harms PW. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma. Journal of Cutaneous Pathology. 41: 831-8. PMID 25263756 DOI: 10.1111/Cup.12387  0.326
2014 Verhaegen ME, Mangelberger D, Weick JW, Vozheiko TD, Harms PW, Nash KT, Quintana E, Baciu P, Johnson TM, Bichakjian CK, Dlugosz AA. Merkel cell carcinoma dependence on bcl-2 family members for survival. The Journal of Investigative Dermatology. 134: 2241-50. PMID 24614157 DOI: 10.1038/Jid.2014.138  0.327
2014 Harms KL, Harms PW, Anderson T, Betz BL, Ross CW, Fullen DR, Hristov AC. Mycosis fungoides with CD20 expression: report of two cases and review of the literature. Journal of Cutaneous Pathology. 41: 494-503. PMID 24467775 DOI: 10.1111/Cup.12299  0.326
2014 Fisher C, McHugh J, Harms P, Edwards P, Danciu T. Primary small cell carcinoma of the parotid gland: a case series Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 118. DOI: 10.1016/J.Oooo.2014.05.050  0.367
2014 Harms PW, Hristov AC, Kim DS, Anens T, Quist MJ, Siddiqui J, Carskadon S, Mehra R, Fullen DR, Johnson TM, Chinnaiyan AM, Palanisamy N. Activating mutations of the oncogene EZH2 in cutaneous melanoma revealed by next generation sequencing Human Pathology: Case Reports. 1: 21-28. DOI: 10.1016/J.Ehpc.2014.07.002  0.338
2013 Arps DP, Harms PW, Chan MP, Fullen DR. Rosette-like structures in the spectrum of spitzoid tumors. Journal of Cutaneous Pathology. 40: 788-95. PMID 23808731 DOI: 10.1111/Cup.12192  0.351
2013 Harms PW, Patel RM, Verhaegen ME, Giordano TJ, Nash KT, Johnson CN, Daignault S, Thomas DG, Gudjonsson JE, Elder JT, Dlugosz AA, Johnson TM, Fullen DR, Bichakjian CK. Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. The Journal of Investigative Dermatology. 133: 936-45. PMID 23223137 DOI: 10.1038/Jid.2012.445  0.399
2010 Yu L, Harms PW, Pouryazdanparast P, Kim DS, Ma L, Fullen DR. Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 23: 1209-14. PMID 20495543 DOI: 10.1038/Modpathol.2010.101  0.371
2003 Harms PW, Chang C. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto. Genes & Development. 17: 2624-9. PMID 14563676 DOI: 10.1101/Gad.1127703  0.585
Show low-probability matches.